Close

Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

Thermo Fisher Scientific, the world leader in serving science, announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now in its eighth year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using TMT. The proprietary TMT and TMTpro reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC.

Winners receive awards of TMT and other mass spectrometry-related reagents, valued at US$11,000. The scientists will use these awards to quantify, normalize and streamline global protein expression studies using mass spectrometry.

A panel of judges from Thermo Fisher and Proteome Sciences, PLC, reviewed the applications and selected the following two recipients based on the scientific merit of their proposals:

  • Stephen Holmes, University of Liverpool
    Grant Title: Inactivating and studying viruses at single-cell level
  • Dick Zijlmans, Stichting Radboud Universiteit
    Grant Title: Identifying true interactors in proximal proteome through target protein perturbation

“We are excited to offer the TMT Research Grant Award for the eighth consecutive year,” said Nicolas Pierre, senior director/general manager, cell & protein consumables, life sciences and laboratory products, Thermo Fisher Scientific. “We received a wide range of diverse submissions from graduate and postdoctoral students. We look forward to seeing what these emerging scientists achieve with our reagents and are eager to get a glimpse from them into the future of multiplex proteomics.”

Thermo Fisher Scientific is showcasing the grant award winners during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, being held June 5-9, 2022 in Booth 400 at the Minneapolis Convention Center, Minneapolis, Minnesota and at the Hilton Minneapolis Grand Ballrooms E, F, G.

Company: Thermo Fisher Scientific


Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.

Latest stories